HALSEY DRUG CO INC/NEW
10-Q, EX-27, 2000-08-09
PHARMACEUTICAL PREPARATIONS
Previous: HALSEY DRUG CO INC/NEW, 10-Q, 2000-08-09
Next: PENNICHUCK CORP, 10QSB, EX-3, 2000-08-09



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED
CONSOLIDATED STATEMENT OF FINANCIAL CONDITION AT JUNE 30, 2000 (UNAUDITED) AND
THE CONDENSED CONSOLIDATED STATEMENT OF INCOME FOR THE SIX MONTHS ENDED JUNE 30,
2000 (UNAUDITED) AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           3,843
<SECURITIES>                                         0
<RECEIVABLES>                                    4,267
<ALLOWANCES>                                       153
<INVENTORY>                                      3,449
<CURRENT-ASSETS>                                11,785
<PP&E>                                          14,296
<DEPRECIATION>                                  11,345
<TOTAL-ASSETS>                                  17,252
<CURRENT-LIABILITIES>                            9,417
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           149
<OTHER-SE>                                    (45,220)
<TOTAL-LIABILITY-AND-EQUITY>                    17,252
<SALES>                                         12,217
<TOTAL-REVENUES>                                12,217
<CGS>                                            8,792
<TOTAL-COSTS>                                    8,792
<OTHER-EXPENSES>                                 3,870
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,116
<INCOME-PRETAX>                                (3,433)
<INCOME-TAX>                                       296
<INCOME-CONTINUING>                            (3,137)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,137)
<EPS-BASIC>                                     (0.22)
<EPS-DILUTED>                                   (0.22)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission